Understand the source comparison
Best Research Peptides for Ulcerative Colitis: Mechanism Comparison
BPC-157 (pentadecapeptide) Angiogenesis and epithelial proliferation VEGF receptor-2 activation, NO synthase stabilization Mucosal healing models, barrier reconstitution studies 10 mcg/kg intraperitoneally Histological damage score, crypt depth, epithelial con
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- BPC-157 (pentadecapeptide)
- Angiogenesis and epithelial proliferation
- VEGF receptor-2 activation, NO synthase stabilization
- Mucosal healing models, barrier reconstitution studies
- 10 mcg/kg intraperitoneally
- Histological damage score, crypt depth, epithelial continuity
- Best for studying regenerative capacity during remission phase. Not acute inflammation suppression
- KPV (Lys-Pro-Val)
- NF-κB nuclear translocation inhibition
- Melanocortin receptor (MC1R, MC3R) pathway
- Local immune modulation studies, cytokine transcription research
- 5–10 mg/kg orally or topically
- TNF-α, IL-6, IL-1β levels; MPO activity; histological inflammation score
- Most valuable for isolating melanocortin-mediated inflammation control without systemic immunosuppression
- Larazotide Acetate
- Tight junction stabilization
- Zonulin receptor (PAR-2) antagonism
- Barrier permeability models, antigen translocation studies
- 0.5–1.0 mg/kg orally
- Lactulose-mannitol ratio, transepithelial electrical resistance (TEER), claudin-1 expression
- Critical for separating barrier defects from immune dysregulation as independent UC pathology drivers